Literature DB >> 17156850

Reliability and validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory (Full and FastScreen scales) in detecting depression in persons with hepatitis C.

Jeannette Golden1, Ronán M Conroy, Anne Marie O'Dwyer.   

Abstract

BACKGROUND: We examined the performance the Beck Depression Inventory (BDI) and its short form (BDI-FS) and the Hospital Anxiety and Depression Scale depression (HADS-D) and anxiety (HADS-A) subscales in detecting depression in a group of patients with hepatitis C.
METHODS: SCID-CV was used to establish DSM-IV diagnosis. Sensitivity, specificity, positive and negative predictive values were used to assess test performance and Cohen's Kappa to measure agreement with DSM diagnosis.
RESULTS: Twenty-five of 88 participants had a DSM-IV depressive diagnosis. There was considerable non-overlap between 'caseness' on the BDI and HADS (Kappa=0.44). The HADS depression subscale had poor sensitivity (52%) and poor agreement with clinical diagnosis (Kappa=0.35). The full BDI had a sensitivity of 88% and a Kappa of 0.54 against a sensitivity of 84% and Kappa of 0.42 for the short form. The HADS anxiety subscale predicted depression as well as the depression subscale (sensitivity 88%, Kappa 0.47).
CONCLUSIONS: Neither the BDI nor the HADS agrees well with the clinical diagnosis of depressive disorder, nor do they agree well with one another. The anxiety subscale of the HADS appears to measure depression at least as well as the depressive subscale.

Entities:  

Mesh:

Year:  2006        PMID: 17156850     DOI: 10.1016/j.jad.2006.10.020

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  16 in total

1.  Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency.

Authors:  David A Sheridan; S H Bridge; M M E Crossey; D J Felmlee; H C Thomas; R D G Neely; S D Taylor-Robinson; M F Bassendine
Journal:  Metab Brain Dis       Date:  2014-03-12       Impact factor: 3.584

Review 2.  Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies.

Authors:  Nicholas Meader; Alex J Mitchell; Carolyn Chew-Graham; David Goldberg; Maria Rizzo; Victoria Bird; David Kessler; Jon Packham; Mark Haddad; Stephen Pilling
Journal:  Br J Gen Pract       Date:  2011-12       Impact factor: 5.386

3.  The additive effects of depressive symptoms and polysubstance use on HIV risk among gay, bisexual, and other men who have sex with men.

Authors:  Kiffer G Card; Nathan J Lachowsky; Heather L Armstrong; Zishan Cui; Lu Wang; Paul Sereda; Jody Jollimore; Thomas L Patterson; Trevor Corneil; Robert S Hogg; Eric A Roth; David M Moore
Journal:  Addict Behav       Date:  2018-03-06       Impact factor: 3.913

4.  Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy.

Authors:  Meike Heeren; Karin Weissenborn; Dimitrios Arvanitis; Martin Bokemeyer; Annemarie Goldbecker; Argyro Tountopoulou; Thomas Peschel; Julian Grosskreutz; Hartmut Hecker; Ralph Buchert; Georg Berding
Journal:  J Cereb Blood Flow Metab       Date:  2011-06-01       Impact factor: 6.200

5.  Does Disability Correlate With Impairment After Hand Injury?

Authors:  Maryam Farzad; Ali Asgari; Fatemeh Dashab; Fereydoun Layeghi; Masoud Karimlou; Seyed Ali Hosseini; Mehdi Rassafiani
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

6.  Utility of the Beck Depression Inventory to screen for and track depression in injection drug users seeking hepatitis C treatment.

Authors:  Paul E Holtzheimer; Jason Veitengruber; Chia C Wang; Meighan Krows; Hanne Thiede; Anna Wald; Peter Roy-Byrne
Journal:  Gen Hosp Psychiatry       Date:  2010-04-02       Impact factor: 3.238

7.  Assessing depression symptoms in those with insomnia: an examination of the beck depression inventory second edition (BDI-II).

Authors:  Colleen E Carney; Christi Ulmer; Jack D Edinger; Andrew D Krystal; Faye Knauss
Journal:  J Psychiatr Res       Date:  2008-10-26       Impact factor: 4.791

Review 8.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014

9.  Improved Detection and Evaluation of Depression in Patients with Chronic Kidney Disease: Validity and Reliability of Screening (PHQ-2) and Diagnostic (BDI-FS-Fr) Tests of Depression in Chronic Kidney Disease.

Authors:  Muaweah Alsaleh; Ludivine Videloup; Thierry Lobbedez; Joelle Lebreuilly; Remy Morello; Angélique Thuillier Lecouf
Journal:  Kidney Dis (Basel)       Date:  2019-03-25

10.  An HIV/STI prevention intervention for internally displaced women in Leogane, Haiti: study protocol for an N-of-1 pilot study.

Authors:  Carmen H Logie; Carolann Daniel; Peter A Newman; Mona R Loutfy
Journal:  BMJ Open       Date:  2012-07-18       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.